We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

viral clearance

Understand Viral Clearance During Anion Exchange Chromatography

Demonstrating viral clearance is essential to the downstream processing of certain drugs. However, due to the specialized nature of this quality control step, services are often outsourced contributing to higher workflow costs and slower turnaround times.

Anion exchange chromatography (AEX) is an established downstream processing step in the manufacture of biologics. It’s a good contributor to overall viral clearance and can be optimized to perform well under typical industry conditions.  

This webinar explores novel design of experiment (DoE) approaches to improve viral clearance in bioprocessing workflows without the need for costly additional steps. 

Watch this webinar to learn more about:

  • The value of DoE approaches in bioprocess optimization
  • Co-elution mechanisms and the prediction of viral clearance performance 
  • Achieving the true viral clearance capacity of your downstream processing workflow
Moira Lynch
Moira Lynch
Innovation Leader
Zhijun (George) Tan
Zhijun (George) Tan
Associate Scientific Director
Brought to you by
Watch this Webinar for FREE Below
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar